ArticleFrontiers in pediatrics2026
Epidemiological analysis of six common respiratory pathogen infections in children in Chengdu from 2022 to 2024.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to describe the epidemiological characteristics of six common respiratory pathogens in children admitted to Chengdu Women's and Children's Central Hospital. Methods: A total of children with respiratory tract infection symptoms, including fever, cough, and headache, who were admitted to the hospital from September 2022 to December 2024 were enrolled in this study. Multiplex reverse transcription quantitative polymerase chain reaction (RT-qPCR) was used to detect the six respiratory pathogens and analyze their epidemiological characteristics. Results: Among the 64,500 included children, 34,505 (53.50%) tested positive for respiratory pathogens. Human rhinovirus (HRV) had the highest positive rate of 18.67% (12,042/64,500), followed by Conclusions: In the post-epidemic era, children remain susceptible to infection by various respiratory pathogens. Therefore, continuous epidemiological analysis and activity surveillance of respiratory pathogens can provide a scientific basis for early clinical diagnosis, promotion of rational drug use, and development of effective prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.